Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 2/2002

01-04-2002 | Original Article

An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer

Authors: Reiki Nishimura, Kazuharu Nagao, Haruhiko Miyayama, Masakazu Matsuda, Ken-ichirou Baba, Yukio Matsuoka, Hiroya Yamashita, Makoto Fukuda

Published in: Breast Cancer | Issue 2/2002

Login to get access
Metadata
Title
An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer
Authors
Reiki Nishimura
Kazuharu Nagao
Haruhiko Miyayama
Masakazu Matsuda
Ken-ichirou Baba
Yukio Matsuoka
Hiroya Yamashita
Makoto Fukuda
Publication date
01-04-2002
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 2/2002
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02967579

Other articles of this Issue 2/2002

Breast Cancer 2/2002 Go to the issue

Case Report

Fibromatosis of the breast: A case report

Original Article

Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer

Case Report

A case of fibromatosis of the breast

Original Article

Sentinel lymph node mapping and biopsy for breast cancer at a rural-based university medical center: Initial Experience with intraparenchymal and intradermal injection routes

Case Report

A male patient with metachronous triple cancers of small cell lung, prostate and breast

Original Article

Breast-conserving therapy versus modified radical mastectomy in the treatment of early breast cancer in Japan
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits